In the past three months we’ve featured 11 biotech startups, working on a range new approaches to tackling major diseases. You can find out more about the startups in the summaries below, or head across to the VentureRadar Database to find thousands more biotech companies like these ones.
Ancilia Biosciences
Ancilia Biosciences develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. The company’s proprietary platform leverages the natural function of CRISPR to produce a new class of live biotherapeutics (LBPs) with engineered immunity to viral phages…. [Read full post] [View VentureRadar Profile] [View Similar Companies to Ancilia Biosciences]
Kanvas Bioscience
Kanvas Bioscience wants to revolutionize microbial research and infectious disease diagnostics with next generation imaging technology that is able to provide deeper information on the spacial organisation and behaviour of microbial communities….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Kanvas Bioscience]
Bo InnoHealth
Bo InnoHealth is a spin-off from the Hong Kong Polytechnic University developing a novel microencapsulation technology which can protect probiotics and probiotics and enable their use in a wider range of applications such as snacks, hot drinks and pet food….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Bo InnoHealth]
Talus Bioscience
Talus Bio aims to revolutionize drug development for gene regulators by enabling the ability to study gene regulatory proteins (GRPs) in a living cell environment. The company’s initial focus is on small-molecule drug development in oncology….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Talus Bioscience]
iTolerance
iTolerance is regenerative medicine company developing a potential cure for Type 1 Diabetes that eliminates the need for chronic immunosuppression of patients. The company’s lead program, ITOL-101, is an adjunct therapy with pancreatic islet cell implant currently in development for the treatment of or as a potential breakthrough cure for Type 1 Diabetes….. [Read full post] [View VentureRadar Profile] [View Similar Companies to iTolerance]
Leyden Labs
Leyden Labs is developing broad spectrum antivirals that target commonalities of viral families, potentially offering protection against known viruses as well as new viruses as they emerge….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Leyden Labs]
Unravel Biosciences
Unravel Biosciences has developed a vertically integrated computational platform to discover better drug targets. Instead of classic pharma, which takes a target of interest and develops drugs to bind that specific target, Unravel’s platform screens many drugs in parallel for their real-world impact (e.g., the complete gene expression profiles and resulting physiological changes), reversing this process to identify the likely target(s) a drug is interacting with….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Unravel Biosciences]
Vernal Biosciences
Vernal Biosciences is aiming to democratize access to mRNA manufacturing technologies, with the goal of accelerating the clinical impact of mRNA as a foundational therapeutic modality….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Vernal Biosciences]
AVVantgarde Bio
AVVantgarde Bio is a gene therapy startup that has developed two adeno-associated viral (AAV)-based platforms with increased transfer capabilities to enable the delivery of large genes….. [Read full post] [View VentureRadar Profile] [View Similar Companies to AVVantgarde Bio]
Kuano
Kuano is aiming to transform the discovery of enzyme inhibitor drugs using a platform that combines quantum transition state simulation and AI led chemistry….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Kuano]
Nuevocor
Nuevocor is a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies. The company’s lead programme is an adeno-associated virus (AAV) – based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the lamin A/C (LMNA) gene….. [Read full post] [View VentureRadar Profile] [View Similar Companies to Nuevocor]